Medtronic stock in focus

Medtronic (MDT) is drawing attention after recent trading, with the stock last closing at $81.93 and showing mixed return patterns across the past week, month, past 3 months, and year to date.

That recent 5.11% 1 day share price gain and 8.42% 7 day share price return come after the stock fell 9.87% over 3 months and is still down 14.70% year to date. The 3 year total shareholder return of 8.68% contrasts with a 23.48% decline over 5 years, suggesting short term momentum is picking up after a weaker longer term stretch.

If Medtronic’s move has you reassessing healthcare exposure, it can help to see what else is gaining attention in the sector, including 40 healthcare AI stocks.

The stock now trades at $81.93, and analyst targets imply a possible gap and only a modest intrinsic discount, so is Medtronic quietly undervalued here, or is the market already pricing in future growth?

Most Popular Narrative: 22.5% Undervalued

Medtronic’s most followed narrative pegs fair value at $105.76 versus the $81.93 last close, framing the recent price move as only part of the story.

Medtronic's investments and breakthroughs in digital health technologies, robotics (Hugo), next-generation sensors, and AI-enabled ecosystems (e.g., spine AiBLE, advanced neuromodulation) align with industry-wide digital transformation and minimally invasive trends. These platforms are expected to expand procedure volumes and capture market share, supporting future top-line growth and higher-margin revenue streams.

Want to see what is backing that valuation gap? The narrative leans heavily on steady revenue gains, fatter margins, and a richer earnings multiple. The exact mix might surprise you.

Result: Fair Value of $105.76 (UNDERVALUED)

However, that story can come under pressure if recent product recalls linger or if underperforming units, such as U.S. Diabetes and parts of MedSurg, keep dragging on growth.

Next Steps

The mixed tone of this story, with risks and rewards both in play, makes it worth checking the numbers yourself and deciding where you stand. If you want a quick, balanced snapshot before making your own call, take a look at the 6 key rewards and 1 important warning sign.

Looking for more investment ideas?

Do not stop with a single stock. Broaden your watchlist with fresh ideas that fit your style, or you may risk missing opportunities others are already studying.

• Target resilient balance sheets by scanning the solid balance sheet and fundamentals stocks screener (46 results) and focus on companies with fundamentals that may better handle tough conditions.
• Hunt for potential value opportunities using the 47 high quality undervalued stocks to spot stocks that trade at prices some investors may see as disconnected from fundamentals.
• Strengthen your income watchlist by reviewing the 10 dividend fortresses and concentrate on companies with higher yields that may appeal to dividend focused portfolios.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.